Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Report ID | 112293 |
Drug Identification Number | 02485540 |
Brand name | HYDROMORPHONE HYDROCHLORIDE INJECTION USP |
Common or Proper name | Hydromorphone Hydrochloride Injection USP |
Company Name | STERINOVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
Strength(s) | 40MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | Box of 30 x 100 mL |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-04-17 |
Actual start date | 2020-04-17 |
Estimated end date | 2020-08-31 |
Actual end date | 2020-08-31 |
Shortage status | Resolved |
Updated date | 2020-09-03 |
Company comments | Resolved |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3005 AVENUE JOSE-MARIA ROSELL SAINT-HYACINTHE, QUEBEC CANADA J2S 0J9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-09-03 | English | Compare |
v3 | 2020-04-18 | English | Compare |
v2 | 2020-04-15 | French | Compare |
v1 | 2020-04-15 | English | Compare |
Showing 1 to 4 of 4